HVC
CLVS

Healthcare Value Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

Healthcare Value Capital’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100,000
Closed -$675K – 23
2020
Q2 		$675K Hold
100,000
– – 1.72% 19
2020
Q1 		$636K Hold
100,000
– – 1.07% 23
2019
Q4 		$1.04M Buy
+100,000
New +$727K 3.07% 13

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Healthcare Value Capital's CLVS Position: Q3 2021 in Review

Healthcare Value Capital held its Clovis Oncology, Inc. (CLVS) position steady in Q3 2021 at 500,000 shares worth $2.23M. The position accounts for 4.4% of the portfolio, ranked #12.

Healthcare Value Capital first reported a position in CLVS in Q3 2014 and has held it in 10 quarters since. The position peaked at $3.16M in Q1 2021. 158 funds tracked by Wall St. Rank hold CLVS as of Q3 2021.

  • Healthcare Value Capital held 500,000 shares of Clovis Oncology, Inc. worth $2.23M as of Q3 2021.
  • Healthcare Value Capital left its Clovis Oncology, Inc. share count unchanged in Q3 2021.
  • Clovis Oncology, Inc. made up 4.4% of Healthcare Value Capital's portfolio in Q3 2021, its #12 holding.
  • Healthcare Value Capital first reported a position in Clovis Oncology, Inc. in Q3 2014 and has held it in 10 quarters since.
  • Healthcare Value Capital's Clovis Oncology, Inc. position peaked at $3.16M in Q1 2021.
  • 158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.